ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 55 filers reported holding ATHIRA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,020 | -77.5% | 1,000 | -67.2% | 0.00% | – |
| Q2 2023 | $8,989 | +69.1% | 3,047 | +43.3% | 0.00% | – |
| Q1 2023 | $5,316 | -75.4% | 2,126 | -68.8% | 0.00% | – |
| Q4 2022 | $21,581 | +7.9% | 6,808 | +2.6% | 0.00% | – |
| Q3 2022 | $20,000 | +1900.0% | 6,637 | +1835.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 343 | +363.5% | 0.00% | – |
| Q1 2022 | $1,000 | – | 74 | +7300.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $10,327,000 | – | 559,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |